Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-squamous NSCLC × Docetaxel × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 29 Prostatic Neoplasms 22 Squamous Cell Carcinoma of Head and Neck 14 Breast Neoplasms 14 Lung Neoplasms 9 Urinary Bladder Neoplasms 6 Stomach Neoplasms 6 Neoplasm Metastasis 5 Carcinoma, Transitional Cell 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms, Castration-Resistant 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Ovarian Neoplasms 4 Neoplasms 4 Small Cell Lung Carcinoma 3 Sarcoma 3 Salivary Gland Neoplasms 3 Recurrence 3 Oropharyngeal Neoplasms 3 Nasopharyngeal Carcinoma 3 Laryngeal Neoplasms 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Squamous Cell 3 Advanced Solid Tumors 3 Adenocarcinoma Of Esophagus 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Solid Tumors 2

Interventions

pyrotinib 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04447118 2025-12-19

PYRAMID-1

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Completed

Non-squamous NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡